Correspondence 0001213900-25-020934 from HeartSciences Inc. (HSCS, HSCSW) (CIK 0001468492) (HSCS)

HeartSciences Inc. (HSCS, HSCSW) (CIK 0001468492)
Date: March 6, 2025 · CIK: 0001468492 · Accession: 0001213900-25-020934

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 024-12572

Date

March 6, 2025

Author

Form

CORRESP

Company

HeartSciences Inc. (HSCS, HSCSW) (CIK 0001468492)

Letter

VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services HeartSciences Inc. Offering Statement on Form 1-A Amended on March 3, 2025 File No. 024-12572

Dear Ms. Sawicki:

Pursuant to Rule 252(e) promulgated under the Securities Act of 1933, as amended (the “Act”), HeartSciences Inc. (the “Company”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) issue a qualification order for the above-referenced Offering Statement on Form 1-A, as amended, so that it may be qualified at 4:00 p.m., Eastern Time on Monday, March 10, 2025, or as soon thereafter as is practicable.

If you have any questions, please contact our counsel Jonathan Shechter, Esq. of Foley Shechter Ablovatskiy LLP at (212) 335-0465. Thank you in advance for your assistance.

Sincerely,
HEARTSCIENCES INC.

Show Raw Text

CORRESP
1
filename1.htm

550 Reserve St., Suite 360

Southlake, TX 76092

March 6, 2025

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Industrial Applications and Services

Washington, D.C. 20549

    Attn:
    Margaret Sawicki

    Re:

    HeartSciences Inc.

    Offering Statement on Form 1-A

    Amended on March 3, 2025

    File No. 024-12572

Dear Ms. Sawicki:

Pursuant to Rule 252(e) promulgated under the
Securities Act of 1933, as amended (the “Act”), HeartSciences Inc. (the “Company”) hereby requests that the U.S.
Securities and Exchange Commission (the “Commission”) issue a qualification order for the above-referenced Offering Statement
on Form 1-A, as amended, so that it may be qualified at 4:00 p.m., Eastern Time on Monday, March 10, 2025, or as soon thereafter as is
practicable.

If you have any questions, please contact our
counsel Jonathan Shechter, Esq. of Foley Shechter Ablovatskiy LLP at (212) 335-0465. Thank
you in advance for your assistance.

    Sincerely,

    HEARTSCIENCES INC.

    By:
    /s/ Danielle Watson

    Name:
    Danielle Watson

    Title:
    Chief Financial Officer

    Cc:

    Andrew Simpson, Chief Executive Officer (HeartSciences Inc.)

    Jonathan Shechter, Esq. (Foley Shechter Ablovatskiy LLP)

    Sasha Ablovatskiy, Esq. (Foley Shechter Ablovatskiy LLP)

SecProbe.io